SAM WAKHAKHA - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock SAM WAKHAKHA's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
SAM WAKHAKHA

SAM WAKHAKHA

Verified

Sub-Editor, New Vision Uganda

Kampala

Biography

I’m a Ugandan journalist working with New Vision, the Government newspaper. I hold a degree in mass communication from Uganda Christian University, having graduated in 2009. I have 10 years of writing and editing with a bias towards agriculture and health reporting. I also worked at The East African newspaper for two years (2010-2011). I write about emerging diseases, technological breakthroughs and agriculture. I’m also a sub-editor. I edit New Vision newspaper, write headlines and do layouts.

Final Covers

Health , Agriculture , Science

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 47

  • How Ukraine war changed life in Africa

    By SAM WAKHAKHA Verified|New Vision UgandaVerifiedWhen the Russia-Ukraine war started three years ago, ordinary people in Uganda did not imagine that it would have an impact on their lives. However, the months that Go to My Subscriptions

    By SAM WAKHAKHA Verified · New Vision Uganda

    Feb. 27, 2025

  • Surviving Kyeyo: Mwine's lessons in saving, investing, and endurance

    By SAM WAKHAKHA Verified|New Vision UgandaVerifiedMany Ugandans who go for kyeyo find it hard to invest back home. For Henry Kitwe Mwine, who hails from Mbarara district, the story has been different because of the Go to My Subscriptions

    By SAM WAKHAKHA Verified · New Vision Uganda

    Mar. 17, 2025

  • Six firms get licence to make crucial HIV injectable

    By SAM WAKHAKHA Verified|New Vision UgandaVerifiedHIV activists have appealed to pharmaceutical companies to ensure that all countries across the world access lenacapavir, the twice-yearly drug that was proven to be successful in preventing HIV infection. The appeal follows a recent decision by HIV infection, the company behind the recent successful studies on drugs, to grant royalty-free licences to six generic drug manufacturers in a move to make it affordable in 120 low and lower-middle-income countries.

    By SAM WAKHAKHA Verified · New Vision Uganda

    Oct. 23, 2024

As seen in

Company Info

New Vision Uganda